Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves new ICL ➤ Home tonometer receives 510(k) clearance ➤ First patient treated in what will be the largest standalone MIGS clinical trial ➤ Topline results from second Phase 3 trial of mydriasis-reversing drug ➤ ASCRS news and events
➤ Launch of Phase 3 clinical trial for presbyopia drop candidate ➤ Topline results for investigational dry eye therapy ➤ Positive findings for photobiomodulation dry AMD treatment ➤ Enrollment completed for investigational oral diabetic retinopathy therapy ➤ Longer-term data from Phase 3 studies evaluating geographic atrophy therapy released ➤ Orphan drug designation granted to investigational retinitis pigmentosa treatment ➤ ASCRS news and events
➤ FDA approves first drug-eluting contact lens ➤ FDA accepts 510(k) submission for new femto-phaco device ➤ Phase 2 study begins to evaluate an immunomodulatory agent for dry eye ➤ Licensing agreement for optic nerve-protective therapy ➤ Phase 3 study to evaluate protein replacement solution for dry eye ➤ Study: Impact of age on SMILE outcomes ➤ ASCRS news and events
With keratoconus, it’s important to diagnose patients as early as possible in order to treat them before more drastic procedures, like a corneal transplant, might be needed. Crosslinking has aided in the early treatment of keratoconus, and now, the use of genetic testing is another tool for doctors to add to their armamentarium.
To patients, eye rubbing might seem innocuous, but to the ophthalmologist, it’s an action that can have sight-threatening consequences and is something that patients should be warned against.
EyeWorld Cornea Editor Clara Chan, MD, discusses “one of her most dramatic cases” involving ocular complications associated with rosacea, previews the content in the Cornea section of this issue, and shares excitement for the ASCRS Annual Meeting.
While it’s hard to determine the incidence of meibomian gland dysfunction (MGD) in children, it can be a serious issue in this population. Two ophthalmologists discussed MGD in pediatric patients and what to look for.
Rosacea can be a significant problem for many patients and may be more prevalent than physicians think. Depending on the subtype, there may be ocular involvement. Three physicians discussed treatment strategies, in addition to sharing what to look for and how to diagnose.
➤ FDA approves device to treat MGD ➤ Standalone MIGS device trial begins ➤ Topline results for novel dry eye candidate ➤ Orphan drug designation granted for topical LHON treatment ➤ Positive safety results in Phase 1/2a trial for investigational treatment of wet AMD ➤ Updates on two investigational RNA therapies ➤ ASCRS news and events
➤ Study: Possible therapy to avoid visual problems induced by space travel ➤ Exploratory study finds investigational eye drop for dry eye safe and tolerable ➤ New drug candidate in development to treat dry eye and ocular pain ➤ Results from year 2 of Phase 3 trial of brolucizumab for DME ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.